Clinical Trials Sponsored by U.S. Army Medical Research and Development Command

Total 321 results

U.S. Army Medical Research and Development Command

Completed

Reference Values for Non-invasive Hydration Status Markers H10-14

Value Orientation

United States
U.S. Army Medical Research and Development Command

Completed

Western Equine Encephalitis Vaccine, Inactivated (WEE)

Virus

United States
U.S. Army Medical Research and Development Command

Completed

Phase 1 Safety and Immunogenicity of Meningococcal Vaccine (HOPS)

Meningococcal Infection, Group B

United States
U.S. Army Medical Research and Development Command

Completed

Safety of and Immune Response to a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults

HIV Infections

United States
U.S. Army Medical Research and Development Command

Completed

Challenge Study of an ETEC Vaccine

Enteritis; Escherichia Coli, Enterotoxigenic

United States
U.S. Army Medical Research and Development Command

Completed

Invaplex 50 Vaccine Dose-Ranging

Diarrhea

United States
U.S. Army Medical Research and Development Command

Completed

Weekly Dosing of Malarone ® for Prevention of Malaria (MALWEEK)

Malaria

United States
U.S. Army Medical Research and Development Command
GlaxoSmithKline

Terminated

Study to Evaluate the Efficacy and Safety of Tafenoquine for the Treatment of Plasmodium Vivax in Adults

Malaria | Plasmodium Vivax

Thailand
U.S. Army Medical Research and Development Command
GlaxoSmithKline

Completed

A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive Infants

Dengue

Thailand
U.S. Army Medical Research and Development Command
GlaxoSmithKline

Completed

A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive Children

Dengue

Thailand
U.S. Army Medical Research and Development Command
GlaxoSmithKline

Completed

A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and Children

Dengue Fever | Dengue Hemorrhagic Fever | Dengue Shock Syndrome

Puerto Rico
U.S. Army Medical Research and Development Command
GlaxoSmithKline

Completed

A Phase II Trial of a Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in Thailand

Dengue

Thailand
U.S. Army Medical Research and Development Command
GlaxoSmithKline

Completed

Safety and Preliminary Efficacy of the Malaria Vaccine Candidates Falciparum Merozoite Protein-1 (FMP1) and SmithKlineBeecham (SKBB) Candidate Malaria Vaccine RTS,S (MAL019)

Malaria, Falciparum

United States
U.S. Army Medical Research and Development Command
GlaxoSmithKline

Completed

A Phase I/II Trial of a Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naïve Children

Dengue Fever

Thailand
Madigan Army Medical Center
U.S. Army Medical Research and Development Command

Terminated

Medical Therapies for Chronic Post-Traumatic Headaches

Headache

United States
U.S. Army Medical Research and Development Command
US Army Medical Research Institute of Infectious Diseases

Withdrawn

Safety and Immunogenicity of Q Fever Vaccine

Q Fever

United States
Tissue Genesis
U.S. Army Medical Research and Development Command

Active, not recruiting

Evaluation of the Tissue Genesis® Icellator Cell Isolation System™ to Treat Critical Limb Ischemia (CLI-DI)

Critical Limb Ischemia

United States
U.S. Army Medical Research and Development Command
SmithKline Beecham

Completed

An Evaluation of Weekly Tafenoquine

Falciparum Parasitaemia
U.S. Army Medical Research and Development Command
Institut Pasteur

Completed

Cosmetic Outcome of Leishmaniasis Scar After WR279396 Application (SCAR)

Scar | Cutaneous Leishmaniasis

Tunisia
U.S. Army Medical Research and Development Command
SIGA Technologies

Available

Tecovirimat Intravenous Treatment for Orthopox Virus Exposure (TPOXX IV)

Orthopox Virus Infection
U.S. Army Medical Research and Development Command
SmithKline Beecham

Completed

A Randomized, Double-blind, Placebo-controlled Evaluation of Increasing Doses of Weekly Tafenoquine for Chemosuppression of Plasmodium Falciparum

Malaria
Terumo BCTbio
U.S. Army Medical Research and Development Command

Completed

Inactivation of Whole Blood With Mirasol (IMPROVEII)

Focus of Study: Radiolabel Recovery and Survival of RBCs

United States
Georgetown University
U.S. Army Medical Research and Development Command

Completed

Exercise in Gulf War Illness (GWI)

Persian Gulf Syndrome | Gulf War Illness

United States
Neumedicines Inc.
U.S. Army Medical Research and Development Command

Completed

NM-IL-12 (rHuIL-12) in Subjects With Open Surgical Wounds

Colostomy Stoma

United States
U.S. Army Medical Research and Development Command
SmithKline Beecham

Completed

Evaluation of Weekly Tafenoquine

Malaria
Georgetown University
U.S. Army Medical Research and Development Command

Completed

Study of Gulf War Illness (GWI) by Comparing GWI and Healthy Veterans

Gulf War Illness | Persian Gulf War Syndrome

United States
HealthPartners Institute
U.S. Army Medical Research and Development Command

Completed

Predictors of Lymphedema Following Breast Cancer Surgery

Breast Cancer | Lymphedema

United States
Georgetown University
U.S. Army Medical Research and Development Command

Completed

Treatment Decision Making in Early-Stage Prostate Cancer

Localized Prostate Cancer

United States
U.S. Army Medical Research and Development Command
Walter Reed Army Medical Center

Terminated

Topical Treatment of Recalcitrant Ulcerative Old World Leishmaniasis With WR 279,396

Cutaneous Leishmaniasis

United States
U.S. Army Medical Research and Development Command
US Army Medical Research Institute of Infectious Diseases

Withdrawn

FY15-14: Tularemia Vaccine Protocol (NDBR Lot 4) (NDBR)

Tularemia

United States
U.S. Army Medical Research and Development Command
US Army Medical Research Institute of Infectious Diseases

Completed

Safety and Immunogenicity Study of Recombinant Ricin Toxin A-Chain Vaccine (RVEc™)

Ricin

United States
U.S. Army Medical Research and Development Command
US Army Medical Research Institute of Infectious Diseases

Withdrawn

IM Recombinant Ricin Toxin Vaccine (RVEc) - 3-Dose Primary Series With Boost

Ricin Poisoning

United States
U.S. Army Medical Research and Development Command
US Army Medical Research Institute of Infectious Diseases

Active, not recruiting

Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine in Healthy Adults (VEE)

Venezuelan Equine Encephalomyelitis Virus Disease

United States
U.S. Army Medical Research and Development Command
US Army Medical Research Institute of Infectious Diseases

Withdrawn

ID Recombinant Ricin Toxin A-Chain Vaccine RVEc™ - 3-Dose Primary Series With Boost

Ricin Poisoning

United States
Gaia Medical Institute
U.S. Army Medical Research and Development Command

Completed

Biomarkers for Noninvasive Assessment of Human Hydration

Dehydration

United States
U.S. Army Medical Research and Development Command
Walter Reed Army Medical Center

Completed

Use of Sodium Stibogluconate as a Treatment for Leishmaniasis

Leishmaniasis

United States
U.S. Army Medical Research and Development Command
Walter Reed Army Medical Center

Completed

Sodium Stibogluconate Treatment of Leishmaniasis

Leishmaniasis

United States
U.S. Army Medical Research and Development Command
Walter Reed Army Medical Center

Completed

Local Heat Therapy Versus Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis

Cutaneous Leishmaniasis

United States
U.S. Army Medical Research and Development Command
Naval Medical Research Center

Withdrawn

A Clinical Trial to Evaluate Plasmodium Falciparum 7G8 and NF54 Challenge Strains (PfSPZ) in a Head-to-head Comparative Study - (ECG-CHMI) (ECG-CHMI)

Plasmodium Falciparum
Huntington Medical Research Institutes
U.S. Army Medical Research and Development Command

Completed

Multimodal Approach to Testing the Acute Effects of Mild Traumatic Brain Injury (mTBI)

Concussion, Mild

United States
U.S. Army Medical Research and Development Command
U.S. Army Office of the Surgeon General

Completed

Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection

Shigellosis

United States
U.S. Army Medical Research and Development Command
United States Army Medical Materiel Development Activity

Completed

Safety and Immunogenicity Study of a Dengue Virus DNA Vaccine

Dengue

United States
Walter Reed Army Institute of Research (WRAIR)
U.S. Army Medical Research and Development Command; U.S. Army Training and...

Completed

Evaluation of Mindfulness and Yoga in Basic Combat Training

Pain | Stress | Health, Subjective | Sleep | Anxiety | Depressive Symptoms | Mood | Leadership | Emotion Regulation | Yoga | Mindfulness | Musculoskeletal Injury | Military Operations | Cohesion, Social

United States
American Burn Association
U.S. Army Medical Research and Development Command

Completed

A Trial of Restrictive Versus Traditional Blood Transfusion Practices in Burn Patients

Burn Injury

United States, Canada, New Zealand
Banyan Biomarkers, Inc
U.S. Army Medical Research and Development Command

Terminated

Fresh Intravenous Blood Samples for TBI Diagnostic Assay Development With Philips Point of Care System (FIRST DOWN)

Traumatic Brain Injury

Netherlands
Ohio State University
U.S. Army Medical Research and Development Command

Completed

The Head Injury-associated Photosensitivity and Pupillary Function (HIPP) Study (HIPP)

Head Injury | Photophobia | Photosensitivity | Traumatic Brain Injury (TBI)

United States
University of Washington
U.S. Army Medical Research and Development Command

Completed

Efficacy Trial of Warrior Check-Up

Alcohol Dependence | Substance Abuse | Alcohol Abuse | Substance Dependence

United States
Nielsen BioSciences, Inc.
U.S. Army Medical Research and Development Command

Completed

Safety, False-Positive Reactions and Sensitizing Properties of Leishmania Tropica Skin Test Antigen

Cutaneous Leishmaniasis

United States
Clemson University
U.S. Army Medical Research and Development Command; Madigan Army Medical Center

Completed

Enhancing mHealth Technology to Activate Chronic Care Patients

Diabetes Mellitus, Type 2

United States
Pennington Biomedical Research Center
U.S. Army Medical Research and Development Command

Not yet recruiting

Military Health and Nutrition Examination Study (MHANES)

Cardiovascular Diseases | Hypertension | Dyslipidemias | Type 2 Diabetes

United States

Clinical Trials Sponsored by U.S. Army Medical Research and Development Command

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations